Friedman Bart (CIK 1368324) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-09). Recent activity: Buy OVID (8,789 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Ovid Therapeutics Inc. (OVID) | Director | Buy | 8,789 | $22,500 |
来源：SEC Form 4 申报文件 · 截至 2026-04-09